Role of TLR9 in hepatic stellate cells and experimental liver fibrosis

Biochemical and Biophysical Research Communications

Volumn 376, Issue 2, 2008, Pages 271-276

  Gäbele, Erwin ^a   Mühlbauer, Marcus ^a   Dorn, Christoph ^a   Weiss, Thomas S ^a   Froh, Matthias ^a   Schnabl, Bernd ^a,b   Wiest, Reiner ^a   Schölmerich, Jürgen ^a   Obermeier, Florian ^a   Hellerbrand, Claus ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Bacterial DNA; CpG motifs; Hepatic fibrosis; Hepatic stellate cell; TLR9

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BACTERIAL DNA; COLLAGEN; MONOCYTE CHEMOTACTIC PROTEIN 1; TOLL LIKE RECEPTOR 9;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL METABOLISM; BILE DUCT LIGATION; CONTROLLED STUDY; CPG ISLAND; DISEASE MARKER; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL; LIVER FIBROSIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR UPREGULATION; STELLATE CELL;

ACTINS; ANIMALS; CHEMOKINE CCL2; CPG ISLANDS; DNA, BACTERIAL; HUMANS; LIVER; LIVER CIRRHOSIS; MICE; MICE, MUTANT STRAINS; MODELS, ANIMAL; TOLL-LIKE RECEPTOR 9;

BACTERIA (MICROORGANISMS); MURINAE; MUS;

EID: 52949125148     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.08.096     Document Type: Article

References (43)

1. Bataller R., and Brenner D.A. Liver fibrosis. J. Clin. Invest. 115 (2005) 209-218
2. Marra F., DeFranco R., Grappone C., Milani S., Pastacaldi S., Pinzani M., Romanelli R.G., Laffi G., and Gentilini P. Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration. Am. J. Pathol. 152 (1998) 423-430
3. Czaja M.J., Geerts A., Xu J., Schmiedeberg P., and Ju Y. Monocyte chemoattractant protein 1 (MCP-1) expression occurs in toxic rat liver injury and human liver disease. J. Leukoc. Biol. 55 (1994) 120-126
4. Bauer T.M., Schwacha H., Steinbruckner B., Brinkmann F.E., Ditzen A.K., Aponte J.J., Pelz K., Berger D., Kist M., and Blum H.E. Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia. Am. J. Gastroenterol. 97 (2002) 2364-2370
5. Adachi Y., Moore L.E., Bradford B.U., Gao W., and Thurman R.G. Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology 108 (1995) 218-224
6. Akira S., Takeda K., and Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2 (2001) 675-680
7. Akira S., and Hemmi H. Recognition of pathogen-associated molecular patterns by TLR family. Immunol. Lett. 85 (2003) 85-95
8. Paik Y.H., Schwabe R.F., Bataller R., Russo M.P., Jobin C., and Brenner D.A. Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology 37 (2003) 1043-1055
9. Paik Y.H., Lee K.S., Lee H.J., Yang K.M., Lee S.J., Lee D.K., Han K.H., Chon C.Y., Lee S.I., Moon Y.M., and Brenner D.A. Hepatic stellate cells primed with cytokines upregulate inflammation in response to peptidoglycan or lipoteichoic acid. Lab. Invest. 86 (2006) 676-686
10. Isayama F., Hines I.N., Kremer M., Milton R.J., Byrd C.L., Perry A.W., McKim S.E., Parsons C., Rippe R.A., and Wheeler M.D. LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 290 (2006) G1318-G1328
11. Seki E., De Minicis S., Osterreicher C.H., Kluwe J., Osawa Y., Brenner D.A., and Schwabe R.F. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat. Med. 13 (2007) 1324-1332
12. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., and Akira S. A Toll-like receptor recognizes bacterial DNA. Nature 408 (2000) 740-745
13. Krieg A.M., Yi A.K., Matson S., Waldschmidt T.J., Bishop G.A., Teasdale R., Koretzky G.A., and Klinman D.M. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374 (1995) 546-549
14. Kadowaki N., Ho S., Antonenko S., Malefyt R.W., Kastelein R.A., Bazan F., and Liu Y.J. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194 (2001) 863-869
15. Zarember K.A., and Godowski P.J. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J. Immunol. 168 (2002) 554-561
16. Hornung V., Rothenfusser S., Britsch S., Krug A., Jahrsdorfer B., Giese T., Endres S., and Hartmann G. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168 (2002) 4531-4537
17. Frances R., Benlloch S., Zapater P., Gonzalez J.M., Lozano B., Munoz C., Pascual S., Casellas J.A., Uceda F., Palazon J.M., Carnicer F., Perez-Mateo M., and Such J. A sequential study of serum bacterial DNA in patients with advanced cirrhosis and ascites. Hepatology 39 (2004) 484-491
18. Such J., Frances R., Munoz C., Zapater P., Casellas J.A., Cifuentes A., Rodriguez-Valera F., Pascual S., Sola-Vera J., Carnicer F., Uceda F., Palazon J.M., and Perez-Mateo M. Detection and identification of bacterial DNA in patients with cirrhosis and culture-negative, nonneutrocytic ascites. Hepatology 36 (2002) 135-141
19. Frances R., Munoz C., Zapater P., Uceda F., Gascon I., Pascual S., Perez-Mateo M., and Such J. Bacterial DNA activates cell mediated immune response and nitric oxide overproduction in peritoneal macrophages from patients with cirrhosis and ascites. Gut 53 (2004) 860-864
20. Liu S., Gallo D.J., Green A.M., Williams D.L., Gong X., Shapiro R.A., Gambotto A.A., Humphris E.L., Vodovotz Y., and Billiar T.R. Role of toll-like receptors in changes in gene expression and NF-kappa B activation in mouse hepatocytes stimulated with lipopolysaccharide. Infect. Immun. 70 (2002) 3433-3442
21. An H., Xu H., Yu Y., Zhang M., Qi R., Yan X., Liu S., Wang W., Guo Z., Qin Z., and Cao X. Up-regulation of TLR9 gene expression by LPS in mouse macrophages via activation of NF-kappaB, ERK and p38 MAPK signal pathways. Immunol. Lett. 81 (2002) 165-169
22. Martin-Armas M., Simon-Santamaria J., Pettersen I., Moens U., Smedsrod B., and Sveinbjornsson B. Toll-like receptor 9 (TLR9) is present in murine liver sinusoidal endothelial cells (LSECs) and mediates the effect of CpG-oligonucleotides. J. Hepatol. 44 (2006) 939-946
23. Gäbele E., Reif S., Tsukada S., Bataller R., Yata Y., Morris T., Schrum L.W., Brenner D.A., and Rippe R.A. The role of p70S6K in hepatic stellate cell collagen gene expression and cell proliferation. J. Biol. Chem. 280 (2005) 13374-13382
24. Muhlbauer M., Bosserhoff A.K., Hartmann A., Thasler W.E., Weiss T.S., Herfarth H., Lock G., Scholmerich J., and Hellerbrand C. A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease. Gastroenterology 125 (2003) 1085-1093
25. Obermeier F., Dunger N., Strauch U.G., Hofmann C., Bleich A., Grunwald N., Hedrich H.J., Aschenbrenner E., Schlegelberger B., Rogler G., Scholmerich J., and Falk W. CpG motifs of bacterial DNA essentially contribute to the perpetuation of chronic intestinal inflammation. Gastroenterology 129 (2005) 913-927
26. Kato A., Homma T., Batchelor J., Hashimoto N., Imai S., Wakiguchi H., Saito H., and Matsumoto K. Interferon-alpha/beta receptor-mediated selective induction of a gene cluster by CpG oligodeoxynucleotide 2006. BMC Immunol. 4 (2003) 8
27. Liu Z., Sakamoto T., Yokomuro S., Ezure T., Subbotin V., Murase N., Contrucci S., and Demetris A.J. Acute obstructive cholangiopathy in interleukin-6 deficient mice: compensation by leukemia inhibitory factor (LIF) suggests importance of gp-130 signaling in the ductular reaction. Liver 20 (2000) 114-124
28. Hellerbrand C., Amann T., Schlegel J., Wild P., Bataille F., Spruss T., Hartmann A., and Bosserhoff A.K. The novel gene MIA2 acts as a tumour suppressor in hepatocellular carcinoma. Gut 57 (2008) 243-251
29. Gao J.J., Diesl V., Wittmann T., Morrison D.C., Ryan J.L., Vogel S.N., and Follettie M.T. Regulation of gene expression in mouse macrophages stimulated with bacterial CpG-DNA and lipopolysaccharide. J. Leukoc. Biol. 72 (2002) 1234-1245
30. Ghosh T.K., Mickelson D.J., Fink J., Solberg J.C., Inglefield J.R., Hook D., Gupta S.K., Gibson S., and Alkan S.S. Toll-like receptor (TLR) 2-9 agonists-induced cytokines and chemokines: I. Comparison with T cell receptor-induced responses. Cell. Immunol. 243 (2006) 48-57
31. Lee J.G., Lee S.H., Park D.W., Lee S.H., Yoon H.S., Chin B.R., Kim J.H., Kim J.R., and Baek S.H. Toll-like receptor 9-stimulated monocyte chemoattractant protein-1 is mediated via JNK-cytosolic phospholipase A2-ROS signaling. Cell. Signal. 20 (2008) 105-111
32. Clements W.D., Erwin P., McCaigue M.D., Halliday I., Barclay G.R., and Rowlands B.J. Conclusive evidence of endotoxemia in biliary obstruction. Gut 42 (1998) 293-299
33. Harry D., Anand R., Holt S., Davies S., Marley R., Fernando B., Goodier D., and Moore K. Increased sensitivity to endotoxemia in the bile duct-ligated cirrhotic rat. Hepatology 30 (1999) 1198-1205
34. Uesugi T., Froh M., Arteel G.E., Bradford B.U., Wheeler M.D., Gäbele E., Isayama F., and Thurman R.G. Role of lipopolysaccharide-binding protein in early alcohol-induced liver injury in mice. J. Immunol. 168 (2002) 2963-2969
35. Yin M., Bradford B.U., Wheeler M.D., Uesugi T., Froh M., Goyert S.M., and Thurman R.G. Reduced early alcohol-induced liver injury in CD14-deficient mice. J. Immunol. 166 (2001) 4737-4742
36. Schuchmann M., Hermann F., Herkel J., van der Zee R., Galle P.R., and Lohse A.W. HSP60 and CpG-DNA-oligonucleotides differentially regulate LPS-tolerance of hepatic Kupffer cells. Immunol. Lett. 93 (2004) 199-204
37. Chace J.H., Hooker N.A., Mildenstein K.L., Krieg A.M., and Cowdery J.S. Bacterial DNA-induced NK cell IFN-gamma production is dependent on macrophage secretion of IL-12. Clin. Immunol. Immunopathol. 84 (1997) 185-193
38. Krieg A.M. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20 (2002) 709-760
39. Yi A.K., Klinman D.M., Martin T.L., Matson S., and Krieg A.M. Rapid immune activation by CpG motifs in bacterial DNA. Systemic induction of IL-6 transcription through an antioxidant-sensitive pathway. J. Immunol. 157 (1996) 5394-5402
40. Anders H.J., Vielhauer V., Eis V., Linde Y., Kretzler M., Perez d.L., Strutz F., Bauer S., Rutz M., Wagner H., Grone H.J., and Schlondorff D. Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice. FASEB J. 18 (2004) 534-536
41. Graham M.J., Crooke S.T., Monteith D.K., Cooper S.R., Lemonidis K.M., Stecker K.K., Martin M.J., and Crooke R.M. In vivo distribution and metabolism of a phosphorothioate oligonucleotide within rat liver after intravenous administration. J. Pharmacol. Exp. Ther. 286 (1998) 447-458
42. Watanabe A., Hashmi A., Gomes D.A., Town T., Badou A., Flavell R.A., and Mehal W.Z. Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via toll-like receptor 9. Hepatology 46 (2007) 1509-1518
43. Hartmann G., Weeratna R.D., Ballas Z.K., Payette P., Blackwell S., Suparto I., Rasmussen W.L., Waldschmidt M., Sajuthi D., Purcell R.H., Davis H.L., and Krieg A.M. Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo. J. Immunol. 164 (2000) 1617-1624